Valuation: Paion AG

Market Cap 1L 2L 1L 1L 2L 1.6Cr 2L 15.9L 6L 79.95L 6L 6L 2.66Cr P/E 2021
-3.89x
P/E 2022 -53x
Enterprise Value 98.67L 1.14Cr 92.84L 84.38L 1.59Cr 109.46Cr 1.61Cr 11Cr 4.27Cr 55Cr 4.29Cr 4.2Cr 182.35Cr EV / Sales 2021
14.1x
EV / Sales 2022 1.22x
Free-Float
100%
Yield 2021 *
-
Yield 2022 -
1 day-8.33%
1 week-5.38%
Current month-20.00%
1 month-20.00%
3 months-24.14%
6 months-67.29%
Current year+233.33%
1 week 0.04
Extreme 0.044
0.05
1 month 0.04
Extreme 0.044
0.06
Current year 0.01
Extreme 0.012
0.23
1 year 0.01
Extreme 0.009
0.23
3 years 0
Extreme 0.0001
5.57
5 years 0
Extreme 0.0001
20.15
10 years 0
Extreme 0.0001
36.78
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2023
Director of Finance/CFO - 01/06/2022
Director TitleAgeSince
Director/Board Member 65 01/10/2012
Director/Board Member 75 01/06/2017
Director/Board Member - 22/05/2019
Date Insider Type Main position Quantity % Market Cap.
27/12/22 Buy

Director

1,121 0.0016%
12/01/21 Buy

Chief Executive Officer

8,500 0.0127%
08/06/20 Buy

Chief Executive Officer

13,158 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+36.36%-5.38%+388.89%-99.09% 4L
-0.11%-1.67%+1.80%+19.90% 4.88TCr
+1.08%+4.03%+486.67%+621.94% 4.54TCr
+1.85%+2.72%+15.58%+91.17% 4.12TCr
+0.61%-0.78%+25.66%+13.07% 3.97TCr
-2.74%-2.74%+17.30%+56.10% 3.26TCr
+1.31%-0.78% - - 1.62TCr
-1.30%-2.66%+27.33%+136.07% 1.67TCr
-0.49%-0.34%+3.45%+29.14% 1.41TCr
-1.70%-0.19%+79.30%+41.51% 1.37TCr
Average -1.00%-1.24%+116.22%+101.09% 2.68TCr
Weighted average by Cap. +0.06%-0.84%+103.14%+152.97%

Financials

2021 2022
Net sales 71.28L 82.53L 67.07L 60.96L 1.15Cr 79Cr 1.16Cr 7.87Cr 3.08Cr 40Cr 3.1Cr 3.03Cr 131.74Cr 3.32Cr 3.85Cr 3.13Cr 2.84Cr 5.35Cr 368.83Cr 5.43Cr 37Cr 14Cr 184.47Cr 14Cr 14Cr 614.44Cr
Net income -2.18Cr -2.52Cr -2.05Cr -1.86Cr -3.5Cr -241.68Cr -3.56Cr -24Cr -9.42Cr -120.87Cr -9.47Cr -9.26Cr -402.61Cr -6L -7L -5L -5L -9L -6.42Cr -9L -63.9L -25.04L -3.21Cr -25.17L -24.62L -11Cr
Net Debt 1.38Cr 1.59Cr 1.3Cr 1.18Cr 2.21Cr 152.75Cr 2.25Cr 15Cr 5.96Cr 76Cr 5.99Cr 5.86Cr 254.46Cr 97.23L 1.13Cr 91.48L 83.14L 1.56Cr 107.86Cr 1.59Cr 11Cr 4.21Cr 54Cr 4.23Cr 4.13Cr 179.69Cr
Logo Paion AG
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.
Employees
64
Date Price Change Volume
14/26/14 0.0440 -8.33% 0
17/26/17 €0.0440 0.00% 121
14/26/14 €0.0440 -8.33% 0
13/26/13 €0.0480 0.00% 0
12/26/12 €0.0480 -3.03% 8,000
  1. Stock Market
  2. Stocks
  3. PA8K Stock